Using the cBioPortal and the same TCGA dataset, we note that BRCA1 (4%) and BRCA2 (5%) are altered in serous ovarian cancer, and the alterations include amplifications and homodeletions. The gene discussed is BRCA2; the disease is ovarian serous adenocarcinoma.